Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome.
about
Respiratory viruses other than influenza virus: impact and therapeutic advancesParainfluenza virusesRespiratory viral infections in hematopoietic stem cell and solid organ transplant recipientsManagement of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignanciesFourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirusNon-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and DexamethasoneDifferences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipientsChanging epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipientsRespiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT.Circulating clinical strains of human parainfluenza virus reveal viral entry requirements for in vivo infection.Prevention and treatment of viral infections in stem cell transplant recipients.Parainfluenza virus type 3 Ab in allogeneic hematopoietic cell transplant recipients: factors influencing post-transplant Ab titers and associated outcomesParainfluenza virus infections in children with hematologic malignanciesManagement of infectious complications in the hematopoietic stem cell transplant recipient.Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologiesDAS181 treatment of hematopoietic stem cell transplant patients with parainfluenza virus lung disease requiring mechanical ventilationMolecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unitCombating infections in hematopoietic stem cell transplant recipients.Long-Term Shedding of Influenza Virus, Parainfluenza Virus, Respiratory Syncytial Virus and Nosocomial Epidemiology in Patients with Hematological DisordersProspective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignanciesRespiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic reviewManagement of respiratory viral infections in hematopoietic cell transplant recipients.Respiratory viral infections after hematopoietic stem cell transplantation in children.Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores.DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation.Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines.Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus.Exposure to novel parainfluenza virus and clinical relevance in 2 bottlenose dolphin (Tursiops truncatus) populations.How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantationSymptomatic parainfluenza virus infections in children undergoing hematopoietic stem cell transplantation.Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients.Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.Comparison of respiratory virus shedding by conventional and molecular testing methods in patients with haematological malignancy.Human parainfluenza virus type 3 in wild nonhuman primates, ZambiaThe challenge of respiratory virus infections in hematopoietic cell transplant recipients.Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation.Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice.Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients
P2860
Q24655957-84C1B3A2-BFF0-486C-936A-1CC9B32850DEQ24682952-CAD66D78-2855-449B-A9A5-7E0CF499D0E2Q26829188-8AA1F90A-4808-4258-8273-E855293C922AQ26853131-698E85B6-FC6D-46D0-8D82-0A03922BC8DDQ27021622-083CB73A-DA87-4992-B86E-87E443C14389Q27312086-EE83422E-935C-4DBE-A0C1-85EBEDB60B6CQ30400403-7CBE6A6E-0FD7-4B1E-92B3-11E65D228F1EQ30403699-0E1581D9-2705-45E6-B4B8-880FE1485AC7Q33722659-EB15937B-868E-4AD9-9DE6-FBD2468CF14AQ33785773-2DB685D3-A956-41BA-B5B6-D6E904CDB65EQ34594547-64FF7086-E227-4116-A951-990DD12E8A88Q34722706-18D4EEF7-BDFD-4F07-B6B3-9C8D43E76B9CQ35095639-98F92E45-0715-482B-901B-3686C7E416DAQ35384114-407A4F6F-628D-4E57-ABA8-BF9631B9482BQ35675979-65ABB46A-044B-493A-916F-EEBAB920C94DQ35724040-A6148CA6-EEB0-4AAB-88F5-D50B4E98372FQ35749971-E9D1F826-386C-43AF-85EA-DFC00F43BF60Q35913866-E7D60123-ADCD-461A-973E-8A8C873A7AE1Q35917135-5662D08E-5A9A-4D41-B4E7-C972BE1E90B6Q35920582-99FB6CA0-F4E2-4B22-9654-49286F41E512Q35945742-99E3CBD5-1374-49F4-9DA5-2FF97BE8F256Q35989482-27ED680C-FEBC-4B50-967E-E0CD370DC4E0Q36386176-C845EB5E-38AB-4836-A1E4-C73DFF2CDA54Q36439896-A2484919-0760-41F6-AAFA-A6818CCA3F22Q36536329-E415C024-C8D8-49ED-A054-FD383FACB42EQ36558322-6A93F694-5771-49EC-99E5-CF793D9B13F1Q36568965-30441722-4F1F-47BC-9E19-D371EBAA4538Q36827280-522CB13C-A915-487A-98CC-73D8F8CEDEDCQ36913826-C3294C42-A57F-4B05-B10B-8C60938F831BQ36944716-E8CCE8EE-00A5-4AEC-A051-F91207C724F1Q36965855-80890092-2C11-4337-B686-7EBAFBD86C99Q37074844-096BA992-3B2F-4DC9-BC93-EF96F2EA5969Q37118406-04CE1FF7-8F28-4366-BA4D-B8F942968EE7Q37143633-45218B84-A77F-464D-A9A7-8B955E7016FDQ37197552-CA492520-9654-4CB2-863E-BF41232A82E6Q37262324-E1695847-5AD6-4111-A577-77CB8BE898B4Q37266577-FCF0AE79-A37D-488F-87FB-604AC4B0253BQ37284406-8E7E3100-911C-41B3-9B9A-C181AEA8A33EQ37333181-6089D2BB-3FB5-4828-9071-A325EE985237Q37390590-6609D3A9-CE87-46A2-BDE6-D84AA15F79D1
P2860
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Parainfluenza virus infections ...... effect on transplant outcome.
@en
Parainfluenza virus infections ...... effect on transplant outcome.
@nl
type
label
Parainfluenza virus infections ...... effect on transplant outcome.
@en
Parainfluenza virus infections ...... effect on transplant outcome.
@nl
prefLabel
Parainfluenza virus infections ...... effect on transplant outcome.
@en
Parainfluenza virus infections ...... effect on transplant outcome.
@nl
P2093
P356
P1433
P1476
Parainfluenza virus infections ...... effect on transplant outcome.
@en
P2093
P304
P356
10.1182/BLOOD.V98.3.573
P407
P577
2001-08-01T00:00:00Z